Medavail Holdings Inc (MDVL)

$2.29

-0.08

(-3.38%)▲

Market is closed - opens 8 PM, 07 Dec 2023

Insights on Medavail Holdings Inc

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 11.46M → 405.0K (in $), with an average decrease of 32.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -12.12M → -5.79M (in $), with an average increase of 33.6% per quarter

  • Vs HITI

    In the last 1 year, Medavail Holdings Inc has experienced a drawdown of -87.9%, however High Tide Inc resisted the overall trend and outperformed by 85.2%

Performance

  • $2.22
    $2.70
    $2.29
    downward going graph

    3.05%

    Downside

    Day's Volatility :17.77%

    Upside

    15.19%

    downward going graph
  • $1.91
    $33.65
    $2.29
    downward going graph

    16.59%

    Downside

    52 Weeks Volatility :94.32%

    Upside

    93.19%

    downward going graph

Returns

PeriodMedavail Holdings IncSector (Consumer Staples)Index (Russel 2000)
3 Months
-71.17%
-1.3%
0.0%
6 Months
-87.71%
-3.4%
0.0%
1 Year
-87.86%
-7.0%
-2.4%
3 Years
-99.62%
4.2%
-6.5%

Highlights

Market Capitalization
4.2M
Book Value
$14.28
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-35.56
Wall Street Target Price
4.0
Profit Margin
-106.17%
Operating Margin TTM
-1099.75%
Return On Assets TTM
-68.15%
Return On Equity TTM
-194.67%
Revenue TTM
43.3M
Revenue Per Share TTM
26.19
Quarterly Revenue Growth YOY
-25.4%
Gross Profit TTM
2.2M
EBITDA
-40.5M
Diluted Eps TTM
-35.56
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Medavail Holdings Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 74.67%

Current $2.29
Target $4.00

Company Financials

FY17Y/Y Change
Revenue
526.0K
↑ 60.86%
Net Income
-4.1M
↓ 6.52%
Net Profit Margin
-771.48%
↑ 556.04%
FY18Y/Y Change
Revenue
360.0K
↓ 31.56%
Net Income
-3.2M
↓ 20.58%
Net Profit Margin
-895.28%
↓ 123.8%
FY19Y/Y Change
Revenue
3.8M
↑ 947.5%
Net Income
-22.3M
↑ 590.88%
Net Profit Margin
-590.48%
↑ 304.8%
FY20Y/Y Change
Revenue
14.0M
↑ 270.41%
Net Income
-26.1M
↑ 17.38%
Net Profit Margin
-187.11%
↑ 403.37%
FY21Y/Y Change
Revenue
22.1M
↑ 58.43%
Net Income
-43.8M
↑ 67.64%
Net Profit Margin
-198.0%
↓ 10.89%
FY22Y/Y Change
Revenue
43.1M
↑ 94.81%
Net Income
-47.6M
↑ 8.68%
Net Profit Margin
-110.45%
↑ 87.55%
Q1 FY22Q/Q Change
Revenue
9.1M
↑ 25.19%
Net Income
-13.3M
↑ 5.14%
Net Profit Margin
-145.66%
↑ 27.77%
Q2 FY22Q/Q Change
Revenue
11.2M
↑ 22.71%
Net Income
-11.7M
↓ 11.73%
Net Profit Margin
-104.77%
↑ 40.89%
Q3 FY22Q/Q Change
Revenue
11.5M
↑ 2.48%
Net Income
-12.1M
↑ 3.44%
Net Profit Margin
-105.76%
↓ 0.99%
Q4 FY22Q/Q Change
Revenue
11.4M
↓ 0.97%
Net Income
-11.1M
↓ 8.67%
Net Profit Margin
-97.53%
↑ 8.23%
Q1 FY23Q/Q Change
Revenue
11.4M
↑ 0.0%
Net Income
-11.1M
↓ 0.01%
Net Profit Margin
-97.52%
↑ 0.01%
Q2 FY23Q/Q Change
Revenue
405.0K
↓ 96.43%
Net Income
-5.8M
↓ 47.68%
Net Profit Margin
-1.4K%
↓ 1332.36%
FY17Y/Y Change
Total Assets
4.8M
↓ 19.56%
Total Liabilities
431.0K
↓ 32.97%
FY18Y/Y Change
Total Assets
4.5M
↓ 7.09%
Total Liabilities
1.6M
↑ 279.12%
FY19Y/Y Change
Total Assets
18.0M
↑ 304.11%
Total Liabilities
114.6M
↑ 6916.4%
FY20Y/Y Change
Total Assets
69.3M
↑ 285.11%
Total Liabilities
8.3M
↓ 92.79%
FY21Y/Y Change
Total Assets
38.1M
↓ 44.98%
Total Liabilities
19.1M
↑ 130.76%
FY22Y/Y Change
Total Assets
33.1M
↓ 13.14%
Total Liabilities
12.3M
↓ 35.46%
Q1 FY22Q/Q Change
Total Assets
27.7M
↓ 27.4%
Total Liabilities
21.1M
↑ 10.52%
Q2 FY22Q/Q Change
Total Assets
52.8M
↑ 90.79%
Total Liabilities
20.0M
↓ 4.89%
Q3 FY22Q/Q Change
Total Assets
49.9M
↓ 5.64%
Total Liabilities
18.5M
↓ 7.49%
Q4 FY22Q/Q Change
Total Assets
33.1M
↓ 33.54%
Total Liabilities
12.3M
↓ 33.63%
Q1 FY23Q/Q Change
Total Assets
33.1M
↑ 0.0%
Total Liabilities
12.3M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
29.9M
↓ 9.73%
Total Liabilities
6.9M
↓ 44.24%
FY18Y/Y Change
Operating Cash Flow
-3.3M
↓ 14.09%
Investing Cash Flow
-1.0M
-
Financing Cash Flow
2.3M
↓ 17.59%
FY19Y/Y Change
Operating Cash Flow
-19.5M
↑ 501.42%
Investing Cash Flow
-402.0K
↓ 61.35%
Financing Cash Flow
25.0M
↑ 966.87%
FY20Y/Y Change
Operating Cash Flow
-28.6M
↑ 46.5%
Investing Cash Flow
-817.0K
↑ 103.23%
Financing Cash Flow
78.6M
↑ 214.57%
FY21Y/Y Change
Operating Cash Flow
-42.5M
↑ 48.49%
Investing Cash Flow
-3.3M
↑ 305.63%
Financing Cash Flow
7.9M
↓ 89.92%
FY22Y/Y Change
Operating Cash Flow
-47.7M
↑ 12.1%
Investing Cash Flow
-2.3M
↓ 31.38%
Financing Cash Flow
42.0M
↑ 429.51%
Q1 FY22Q/Q Change
Operating Cash Flow
-13.3M
↓ 7.54%
Investing Cash Flow
-852.0K
↓ 18.47%
Financing Cash Flow
-23.0K
↓ 97.11%
Q2 FY22Q/Q Change
Operating Cash Flow
-12.5M
↓ 6.14%
Investing Cash Flow
-874.0K
↑ 2.58%
Financing Cash Flow
37.3M
↓ 162065.22%
Q3 FY22Q/Q Change
Operating Cash Flow
-11.6M
↓ 7.08%
Investing Cash Flow
-171.0K
↓ 80.43%
Financing Cash Flow
9.7M
↓ 73.87%
Q4 FY22Q/Q Change
Operating Cash Flow
-10.4M
↓ 10.27%
Investing Cash Flow
-377.0K
↑ 120.47%
Financing Cash Flow
-5.0M
↓ 151.3%
Q1 FY23Q/Q Change
Operating Cash Flow
-10.4M
↑ 0.0%
Investing Cash Flow
-41.0K
↓ 89.12%
Financing Cash Flow
-5.0M
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-4.4M
↓ 57.82%
Investing Cash Flow
-41.0K
↑ 0.0%
Financing Cash Flow
-17.0K
↓ 99.66%

Technicals Summary

Sell

Neutral

Buy

Medavail Holdings Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Medavail Holdings Inc
Medavail Holdings Inc
-35.86%
-87.71%
-87.86%
-99.62%
100.85%
Petmed Express Inc
Petmed Express Inc
8.59%
-49.61%
-59.8%
-73.38%
-67.29%
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
-5.79%
-34.95%
-49.47%
-51.66%
-75.27%
111 Inc
111 Inc
-25.53%
-33.96%
-37.5%
-73.04%
-78.07%
High Tide Inc
High Tide Inc
10.69%
27.38%
-2.73%
-82.17%
-82.17%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Medavail Holdings Inc
Medavail Holdings Inc
NA
NA
NA
0.0
-1.95
-0.68
0.0
14.28
Petmed Express Inc
Petmed Express Inc
1191.0
NA
2.58
0.4
-0.05
-0.03
0.13
5.57
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
7.19
NA
6.16
3.99
-0.12
0.01
0.09
23.18
111 Inc
111 Inc
NA
NA
NA
0.0
-0.51
-0.05
0.0
-6.07
High Tide Inc
High Tide Inc
NA
NA
NA
-0.12
-0.34
-0.02
0.0
2.12
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Medavail Holdings Inc
Medavail Holdings Inc
Buy
$4.2M
100.85%
NA
-106.17%
Petmed Express Inc
Petmed Express Inc
Sell
$162.6M
-67.29%
1191.0
-2.25%
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
Hold
$17.9B
-75.27%
7.19
-2.21%
111 Inc
111 Inc
Buy
$158.7M
-78.07%
NA
-1.98%
High Tide Inc
High Tide Inc
Buy
$120.9M
-82.17%
NA
-13.34%

Institutional Holdings

  • Redmile Group, LLC

    42.88%

  • Ally Bridge Group (NY) LLC

    7.31%

  • Alyeska Investment Group, L.P.

    7.21%

  • PURA VIDA INVESTMENTS, LLC

    3.60%

  • Cigna Investments Inc

    2.96%

  • Vanguard Group Inc

    1.30%

Corporate Announcements

  • Medavail Holdings Inc Earnings

    Medavail Holdings Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

medavail inc. is the developer of the medcenter automated dispensing and medication management technologies. the company designs and manufactures pharmacist-controlled automated prescription medicine dispensing vaults, similar in appearance to atms. intended for deployment in hospitals, pharmacies, medical clinics, and other locations. the company integrates advanced robotics, two-way video teleconferencing, and a secure network for patients medical information to create a prescription medication dispensing system.

Organization
Medavail Holdings Inc
Employees
279
CEO
Ms. Ramona Seabaugh
Industry
Technology Services

Discover More

FAQs